Kimura A, et al. - For this research, the physicians examined the significance of heat shock protein 110 (HSP110) in gastric cancer (GC) patients with peritoneal metastasis undergoing hyperthermo-chemotherapy. In GC patients, the expression of nuclear HSP110 could be a new marker of chemosensitivity and a therapeutic target for patients who were tolerant to existing hyperthermo-chemotherapies.